Biotech startups in the United States that raised money in the last 12 months
121 biotech startups based in the United States announced or filed 130 venture rounds in the last 12 months, $3.5B of it stated. 26 of the rounds came in the last 90 days. The largest: Beeline Medicines (Series A · $426.3M), LifeMine (Venture round · $263M) and Solstice Oncology (Series A · $225M). 23 of these startups are hiring now, with 133 open roles.
The newest rounds
| Startup | Round | Date | Open roles |
|---|---|---|---|
 Opentrons | Series E · $40M | 29 Oct 2026 | – |
 Atlas BioCreandum, First Momentum | Pre-seed · $12.5M | 27 Oct 2026 | – |
 Hexagon Bio | Series C · $62M | 23 Oct 2026 | 1 |
 GOA Therapeutics | Venture round · $300kSEC Form D | 22 Oct 2026 | – |
 MitoAI | Venture round · $5.4MSEC Form D | 22 Oct 2026 | – |
 Warp Sciences | Venture round · $194.6MSEC Form D | 16 Oct 2026 | 8 |
 All Rights Reserved | Venture round · $925kSEC Form D | 9 Oct 2026 | – |
 Gale Force Aesthetics | Convertible note · $800kSEC Form D | 8 Oct 2026 | – |
 Antheia | Venture round · $17M | 6 Oct 2026 | 3 |
 Primrose Bio | Venture round | 2 Oct 2026 | – |
 Kaigene | Venture round · $55MSEC Form D | 30 Sep 2026 | – |
 Qimmune | Venture round · $25kSEC Form D | 24 Sep 2026 | – |
 Nix Biosensors | Series A · $10M | 18 Sep 2026 | – |
 ZymoChem | Venture round · $25.1MSEC Form D | 18 Sep 2026 | 2 |
 Vetmab Biosciences | Venture round · $11.4MSEC Form D | 17 Sep 2026 | – |
 Jupiter Biomedical Research | Venture round · $30kSEC Form D | 15 Sep 2026 | – |
 EnteroTrack | Convertible note · $2MSEC Form D | 15 Sep 2026 | – |
 Mithrl | Series A · $20M | 15 Sep 2026 | 4 |
 Oncobiomix | Convertible note · $100kSEC Form D | 14 Sep 2026 | – |
 Verinomics | Venture round · $2.7MSEC Form D | 9 Sep 2026 | – |
 Solstice Oncology | Series A · $225M | 9 Sep 2026 | – |
 Moonwalk Biosciences, Inc. | Series B · $70M | 8 Sep 2026 | – |
 Cloverleaf Bio | Seed · $33M | 8 Sep 2026 | 3 |
 Aqur Biosciences | Venture round · $1.5MSEC Form D | 3 Sep 2026 | – |
 seqWell | Venture round · $960kSEC Form D | 1 Sep 2026 | – |
| Cloverleaf Bio | Venture round · $14.8MSEC Form D | 24 Aug 2026 | 3 |
 MalarVx | Convertible note · $125kSEC Form D | 8 Aug 2026 | – |
 Vedanta Biosciences, Inc | Venture round · $60M | 6 Aug 2026 | – |
 LifeMine | Venture round · $263M | 6 Aug 2026 | 1 |
 InSitu Biologics | Convertible note · $1.3MSEC Form D | 4 Aug 2026 | – |
 Strikegraph | Venture round · $1.4MSEC Form D | 4 Aug 2026 | – |
 Hyku Biosciences | Venture round · $8.6MSEC Form D | 30 Jul 2026 | – |
 Checker Spot | Venture round · $27.4MSEC Form D | 27 Jul 2026 | – |
 Accipiterbio | Venture round · $10.5MSEC Form D | 21 Jul 2026 | – |
 Theradaptive | Venture round · $36.2MSEC Form D | 21 Jul 2026 | – |
 BigHat Biosciences | Venture round · $75.1MSEC Form D | 17 Jul 2026 | 15 |
 Estrigenix Therapeutics | Venture round · $1MSEC Form D | 17 Jul 2026 | – |
 FluidForm Bio | Venture round · $1.7MSEC Form D | 16 Jul 2026 | – |
 Enumera Molecular | Venture round · $12.3MSEC Form D | 16 Jul 2026 | – |
 Genomenon | Venture round · $6MSEC Form D | 15 Jul 2026 | 1 |
 SwabBot | Convertible note · $250kSEC Form D | 7 Jul 2026 | – |
 Hexamer Therapeutics | Venture round · $500kSEC Form D | 7 Jul 2026 | – |
 SelSym Biotech | Convertible note · $500kSEC Form D | 2 Jul 2026 | – |
 Pluristyx | Venture round · $9.8MSEC Form D | 1 Jul 2026 | – |
 Baylor Genetics | Venture round · $50MSEC Form D | 1 Jul 2026 | – |
 Beeline Medicines | Series A · $426.3M | 30 Jun 2026 | 27 |
 GenerativeXNissay Capital, Salesforce Ventures | Series A · $4M | 29 Jun 2026 | – |
 Sinopia Biosciences | Venture round · $2.8MSEC Form D | 29 Jun 2026 | – |
 Cellular Logistics | Convertible note · $50kSEC Form D | 25 Jun 2026 | – |
 AvantGuard Inc. | Seed · $1.7M | 24 Jun 2026 | – |
The largest rounds
| Startup | Round | Date | Open roles |
|---|---|---|---|
| Beeline Medicines | Series A · $426.3M | 30 Jun 2026 | 27 |
| LifeMine | Venture round · $263M | 6 Aug 2026 | 1 |
| Solstice Oncology | Series A · $225M | 9 Sep 2026 | – |
| Warp Sciences | Venture round · $194.6MSEC Form D | 16 Oct 2026 | 8 |
 CREATE MedicinesNewpath Partners, ARCH Venture Partners | Series B · $122M | 14 May 2026 | – |
| Solstice Oncology | Venture round · $121.3MSEC Form D | 20 Feb 2026 | – |
 Atavistik Bio | Series B · $120M | 17 Dec 2025 | – |
 Profluent | Venture round · $106M | 21 Nov 2025 | 12 |
 Earli | Venture round · $105M | 17 Mar 2026 | 2 |
 Addition Therapeutics | Venture round · $100M | 17 Dec 2025 | 3 |
By country
More on startups in the United States
New rounds, the day they land
Follow the startups and investors you care about: Alion tells you when one raises, starts hiring or opens a role that fits you.
Questions
Which biotech startups in the United States raised money recently?
121 biotech startups based in the United States announced or filed 130 venture rounds in the last 12 months, $3.5B of it stated. 26 of the rounds came in the last 90 days. The largest: Beeline Medicines (Series A · $426.3M), LifeMine (Venture round · $263M) and Solstice Oncology (Series A · $225M). 23 of these startups are hiring now, with 133 open roles.
Where do these rounds come from?
From the startups' own announcements and the press, from SEC Form D filings in the United States and from the share allotments company registers publish (a filing is marked as one in the list). One round per startup, type and week; amounts as stated, in US dollars.
Are these startups hiring?
23 of the 121 startups have open roles on their own careers boards right now, 133 roles in all; each count links to them.